Joseph Savitt1, Michaela Mathews2. 1. Department of Neurology, University of Maryland School of Medicine, 110 South Paca Street 3rd Floor, Baltimore, MD, 21201, USA. jsavitt@som.umaryland.edu. 2. Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract
PURPOSE OF REVIEW: This article discusses visual disorders in both Parkinson disease (PD) and other Parkinsonian disorders. It is organized largely by the anatomical site of pathology and emphasizes practical treatments. Targeted treatment options include medications, surgery, occupational, and physical therapies as well as optical aids. RECENT FINDINGS: The causes of visual complaints in Parkinson disease and other similar disorders are being more clearly identified. A new medication approved specifically to treat hallucinations in PD now is available. There is increased understanding of the important role that an ophthalmologist can play in the care of these patients. Finally, research and therapeutic development are unmet needs in accessing and treating visual complaints in PD and Parkinsonian disorders. A better understanding of Parkinson-related visual complaints and of available treatment options is important to optimize patient safety and quality of life. Vision impairment leads to difficulties in many common activities including reading, ambulating, and driving. Falls and injuries, made more likely because of impaired vision, result in an early loss of independence. Awareness of the problem, patient education, ophthalmologic care, selected therapeutics, physical therapy, and occupational therapy are crucial to maximizing quality of life in these patients.
PURPOSE OF REVIEW: This article discusses visual disorders in both Parkinson disease (PD) and other Parkinsonian disorders. It is organized largely by the anatomical site of pathology and emphasizes practical treatments. Targeted treatment options include medications, surgery, occupational, and physical therapies as well as optical aids. RECENT FINDINGS: The causes of visual complaints in Parkinson disease and other similar disorders are being more clearly identified. A new medication approved specifically to treat hallucinations in PD now is available. There is increased understanding of the important role that an ophthalmologist can play in the care of these patients. Finally, research and therapeutic development are unmet needs in accessing and treating visual complaints in PD and Parkinsonian disorders. A better understanding of Parkinson-related visual complaints and of available treatment options is important to optimize patient safety and quality of life. Vision impairment leads to difficulties in many common activities including reading, ambulating, and driving. Falls and injuries, made more likely because of impaired vision, result in an early loss of independence. Awareness of the problem, patient education, ophthalmologic care, selected therapeutics, physical therapy, and occupational therapy are crucial to maximizing quality of life in these patients.
Authors: Carlo Nucci; Alessio Martucci; Massimo Cesareo; Francesco Garaci; Luigi Antonio Morrone; Rossella Russo; Maria Tiziana Corasaniti; Giacinto Bagetta; Raffaele Mancino Journal: Prog Brain Res Date: 2015-07-02 Impact factor: 2.453
Authors: Prabitha Urwyler; Tobias Nef; René Müri; Neil Archibald; Selina Margaret Makin; Daniel Collerton; John-Paul Taylor; David Burn; Ian McKeith; Urs Peter Mosimann Journal: Am J Geriatr Psychiatry Date: 2015-10-21 Impact factor: 4.105
Authors: Julia Das; Rosie Morris; Gill Barry; Rodrigo Vitorio; Paul Oman; Claire McDonald; Richard Walker; Samuel Stuart Journal: PLoS One Date: 2022-10-07 Impact factor: 3.752